The benefits, limitations and opportunities of preclinical models for neonatal drug development

Increased research to improve preclinical models to inform the development of therapeutics for neonatal diseases is an area of great need. This article reviews five common neonatal diseases – bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, perinatal hypoxic–ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Campion, Sarah, Inselman, Amy, Hayes, Belinda, Casiraghi, Costanza, Joseph, David, Facchinetti, Fabrizio, Salomone, Fabrizio, Schmitt, Georg, Hui, Julia, Davis-Bruno, Karen, Van Malderen, Karen, Morford, LaRonda, De Schaepdrijver, Luc, Wiesner, Lutz, Kourula, Stephanie, Seo, Suna, Laffan, Susan, Urmaliya, Vijay, Chen, Connie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066504/
https://www.ncbi.nlm.nih.gov/pubmed/35466995
http://dx.doi.org/10.1242/dmm.049065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066504/
https://www.ncbi.nlm.nih.gov/pubmed/35466995
http://dx.doi.org/10.1242/dmm.049065

Ejemplares similares